Guaifenesin And Dextromethorphan Hbr Tablet, Extended Release
Product Images NDC 65162-038

6 FDA label images from Amneal Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Dextromethorphan Hbr (NDC 65162-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

600 mg- Blister Pack (Guaifenesin And Dextromethorphan Hbr Extended Rele 1)

600 mg- Blister Pack (Guaifenesin And Dextromethorphan Hbr Extended Rele 1)
Blister pack label for Guaifenesin and Dextromethorphan HBr Extended-Release Tablet 600 mg/30 mg. The label instructs to push tablets through foil and includes distributor information for Amneal Pharmaceuticals LLC, Bridgewater, NJ. Spaces for lot and expiration dates are shown but not filled in.*
FDA Label Image

600 mg- 30ct Label (Guaifenesin And Dextromethorphan Hbr Extended Rele 2)

600 mg- 30ct Label (Guaifenesin And Dextromethorphan Hbr Extended Rele 2)
Label for Guaifenesin and Dextromethorphan HBr Extended-Release Tablets, 600 mg / 30 mg strength, oral extended-release tablets by Amneal Pharmaceuticals LLC. The label highlights the 12-hour dosing and 30 extended-release tablets per package, includes directions for use, and a comparison to Mucinex DM active ingredients.*
FDA Label Image

600 mg- 30ct Carton (Guaifenesin And Dextromethorphan Hbr Extended Rele 3)

600 mg- 30ct Carton (Guaifenesin And Dextromethorphan Hbr Extended Rele 3)
Packaging label for Guaifenesin and Dextromethorphan HBr Extended-Release Tablets, 600 mg/30 mg. The label shows the product as expectorant and cough suppressant in extended-release oral tablet form. It includes branding by Amneal Pharmaceuticals LLC and a package count of 30 extended-release tablets. The label features detailed Drug Facts information, warnings, directions, inactive ingredients, and storage instructions. The barcode and NDC 65162-038-03 are also visible.*
FDA Label Image

600 mg- 60ct Label (Guaifenesin And Dextromethorphan Hbr Extended Rele 4)

600 mg- 60ct Label (Guaifenesin And Dextromethorphan Hbr Extended Rele 4)
Label for Guaifenesin and Dextromethorphan HBr Extended-Release Tablets, 600 mg/30 mg, manufactured by Amneal Pharmaceuticals LLC. The label indicates this product is an expectorant and cough suppressant with a 12-hour extended release. Package contains 60 extended-release tablets. Directions for use and warnings are included along with the barcode and NDC number 65162-038-06.*
FDA Label Image

600 mg- 60ct Carton (Guaifenesin And Dextromethorphan Hbr Extended Rele 5)

600 mg- 60ct Carton (Guaifenesin And Dextromethorphan Hbr Extended Rele 5)
Label for Guaifenesin and Dextromethorphan HBr Extended-Release Tablets containing 600 mg of Guaifenesin and 30 mg of Dextromethorphan HBr. The label indicates the product is an expectorant and cough suppressant and contains 60 extended-release tablets. It is distributed by Amneal Pharmaceuticals LLC. The label includes drug facts, usage instructions, warnings, inactive ingredients, and contact information.*
FDA Label Image

600 mg Blister Carton (Guaifenesin And Dextromethorphan Hbr Extended Rele 6)

600 mg Blister Carton (Guaifenesin And Dextromethorphan Hbr Extended Rele 6)
Packaging label for Guaifenesin and Dextromethorphan HBr Extended-Release Tablets, 600 mg/30 mg. The oral tablets are indicated as expectorant and cough suppressant, available in a carton of 20 extended-release tablets. The label shows the product is distributed by Amneal Pharmaceuticals LLC and includes drug facts and usage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.